Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent

Marisa H Miceli1, Carol A Kauffman2

  • 1Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System.

Insights

Isavuconazole is a new antifungal medication effective against various fungi, including invasive aspergillosis and mucormycosis. Clinical trials show it is as effective as voriconazole and well-tolerated with fewer drug interactions.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Isavuconazole is an extended-spectrum triazole antifungal agent.
  • It demonstrates activity against yeasts, molds, and dimorphic fungi.
  • Approved for invasive aspergillosis and mucormycosis treatment.

Purpose of the Study:

  • To evaluate the efficacy and safety of isavuconazole.
  • Compare isavuconazole with voriconazole for invasive aspergillosis.
  • Assess isavuconazole in invasive mucormycosis treatment.

Main Methods:

  • Randomized, double-blind clinical trial for invasive aspergillosis.
  • Open-label trial for invasive mucormycosis (primary and salvage therapy).
  • Pharmacokinetic and safety assessments in patients and volunteers.

Main Results:

  • Isavuconazole demonstrated non-inferior efficacy to voriconazole in invasive aspergillosis.
  • Efficacy in invasive mucormycosis was similar to amphotericin B and posaconazole.
  • Isavuconazole was well-tolerated with a favorable safety profile and fewer drug-drug interactions.

Conclusions:

  • Isavuconazole is an effective and well-tolerated treatment option for invasive aspergillosis and mucormycosis.
  • Its predictable pharmacokinetics and favorable drug interaction profile are advantageous.
  • Further clinical experience will define its role in treating invasive fungal infections.

Related Concept Videos

Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
977
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
883
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
387
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
958
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.3K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K